Patients and Trials.

AmpliMed® Corporation is currently planning and/or recruiting patients for clinical studies in a number of areas. To learn more about the upcoming studies, click on the indication below.

          Current Study:

• Protocol AMP-019: Pancreatic Cancer

Planned Studies:

• Protocol AMP-024: Non Small Cell Lung Cancer
• Protocol AMP-008: Malignant Melanoma
  
  

Contact:

For additional information about AmpliMed Corporation and the clinical trials, please have your physician contact one of the centers listed under the indications noted above.

 

 

Evan M. Hersh, M.D.
Vice President for Medical Affairs
or
Thomas Williams, M.D.
Chief Medical Officer
AmpliMed Corporation
4380 North Campbell Avenue, Suite 205
Tucson, AZ 85718

Phone: 520.529.1000 / Fax: 520.529.3001